KO
KOREA PHARMA Co., Ltd.
032300 | KO
Overview
Corporate Details
- ISIN(s):
- KR7032300006
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약공단3길 87, 화성시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.2 MB | ||
| 2025-08-07 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 127.8 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-05-14 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 137.1 KB | ||
| 2025-04-01 00:00 |
M&A Activity
합병등종료보고서(자산양수도)
|
Korean | 14.9 KB | ||
| 2025-03-28 00:00 |
AGM Information
정기주주총회결과
|
Korean | 30.2 KB | ||
| 2025-03-28 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.5 KB | ||
| 2025-03-20 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 572.5 KB | ||
| 2025-03-14 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 18.5 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 18.9 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 103.6 KB | ||
| 2025-03-12 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 4.3 KB | ||
| 2025-03-07 00:00 |
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 10.8 KB | ||
| 2025-03-07 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 8.5 KB | ||
| 2025-02-07 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 124.9 KB |
Automate Your Workflow. Get a real-time feed of all KOREA PHARMA Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for KOREA PHARMA Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KOREA PHARMA Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops lipid-signaling therapeutics for cancer, pain, anxiety, and depression.
United States of America
ARTL
United States of America
ARTL
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden
ACE
Sweden
ACE
Biopharma using proprietary TransCon® tech to develop therapies for rare diseases & oncology.
United States of America
ASND
United States of America
ASND
Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.
United States of America
AAPG
United States of America
AAPG
Japan
4886
Developing a nano-platform for rapid, sublingual delivery of reformulated medications.
United States of America
ASBP
United States of America
ASBP
Clinical-stage biopharma developing small-molecule antivirals for herpes, HBV, and HDV.
United States of America
ASMB
United States of America
ASMB
Offers branded prescription drugs for neurology, pain, and CNS to US patients.
United States of America
ASRT
United States of America
ASRT
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan
4503
Japan
4503
Global biopharma developing medicines for oncology, cardiovascular, respiratory & rare diseases.
United Kingdom
AZN
United Kingdom
AZN